Switzerland · Series B startup

Who invested in Nuclidium

2 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$133Mraised across 2 rounds since 2025, from 2 sources

$99MSeries B$34MSeries B
Latest round
Series B, $34MMay 2026
Biggest round
$99MSeries B · Jul 2025
Investors
12 (4 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$99MSeries B$34MSeries B
First round
Series B, $99M
Jul 2025
Biggest round
$99M
Series B · Jul 2025
Between rounds
10 months
from the last two

The rounds

  1. May 2026
    Series B$34M4 returning

    Source recorded

  2. Jul 2025

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

EIC AcceleratorGovernment2rounds
EurazeoPrivate equity2rounds
Highlight CapitalVC firm2rounds
KurmaPartnersVC firm2rounds
Wellington PartnersVC firm1round, led 1
Angelini VenturesVC firm1round, led 1
Neva SGRVC firm1round, led 1
Kurma Growth Opportunities FundGrowth equity1round, led 1
Bayern KapitalGovernment1round
nrw.bankVC firm1round
VIVES PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Nuclidium

Who invested in Nuclidium?

Nuclidium's investors include EIC Accelerator, Eurazeo, Highlight Capital, KurmaPartners and Wellington Partners, and 7 more on record.

How much has Nuclidium raised?

Nuclidium has raised $133M across 2 rounds since 2025.

When did Nuclidium last raise?

Nuclidium's most recent round was a Series B of $34M in May 2026.

What was Nuclidium's biggest round?

Nuclidium's largest round on record is $99M (Series B), in Jul 2025, led by Wellington Partners.

Who backed Nuclidium first?

Nuclidium's first round on record, in Jul 2025, was backed by Wellington Partners, Angelini Ventures and Neva SGR and 9 others.

What stage is Nuclidium at?

Nuclidium's latest named round is a Series B, in May 2026.

Where is Nuclidium based?

Nuclidium is based in Switzerland.

Who led Nuclidium's rounds?

Wellington Partners led the Series B in 2025.

Companies like Nuclidium

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.